Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Any nephronophthisis in which the cause of the disease is a mutation in the MAPKBP1 gene.
Features include always present findings: Reduced kidney function (renal insufficiency) and Nephronophthisis; and common findings: Stage 5 chronic kidney disease and Sideways curvature of the spine (scoliosis). 6 total HPO annotations.
Organ System | Phenotype Count | Example Features |
|---|---|---|
Kidneys and urinary system | 4 | Stage 5 chronic kidney disease, Reduced kidney function (renal insufficiency), Renal cyst |
MAPKBP1 encodes mitogen-activated protein kinase binding protein 1 (1,514 aa). Negative regulator of NOD2 function. It down-regulates NOD2-induced processes such as activation of NF-kappa-B signaling, IL8 secretion and antibacterial response. Involved in JNK signaling pathway Highest expression in Brain Cerebellum (124.0 TPM) and Brain Cerebellar Hemisphere (107.6 TPM).
Nephronophthisis 20 is caused by mutations in the MAPKBP1 gene on chromosome 15.
MAPKBP1 is classified as a druggable target (Kinase category) with score 0.0.
Genetic testing for MAPKBP1 is available. Testing is considered confirmatory for diagnosis.
Phenotype severity distribution: 2 always present features, 2 common features.
No clinical trials have been registered for nephronophthisis 20.
12 publications have been identified in PubMed for nephronophthisis 20. Research spans Case Report / Case Series (42%), Review / Meta-Analysis (25%), and Basic Science / Preclinical (17%).
Research Type | Count | % of Total |
|---|---|---|
Patient case studies | 5 | 42% |
Data assembled from 6 of 12 sources · Last updated Sep 20, 2026, 3:00 PM UTC
Online Mendelian Inheritance in Man
Genetic and Rare Diseases Info Center
Bones and joints |
1 |
Sideways curvature of the spine (scoliosis) |
3 |
25% |
Laboratory research | 2 | 17% |
Disease patterns and progression | 1 | 8% |
New treatment approaches | 1 | 8% |
Dahmer-Heath M (2026). [PMID: 40836044](https://pubmed.ncbi.nlm.nih.gov/40836044/). *Pediatric nephrology (Berlin, Germany)*. [Review / Meta-Analysis]
Yahya D (2025). [PMID: 40729233](https://pubmed.ncbi.nlm.nih.gov/40729233/). *Reports (MDPI)*. [Case Report / Case Series]
Ebert LK (2025). [PMID: 40713016](https://pubmed.ncbi.nlm.nih.gov/40713016/). *American journal of physiology. Renal physiology*. [Basic Science / Preclinical]
Demirtas İ (2025). [PMID: 41316455](https://pubmed.ncbi.nlm.nih.gov/41316455/). *Journal of medical case reports*. [Case Report / Case Series]
Otludil B (2025). [PMID: 40134261](https://pubmed.ncbi.nlm.nih.gov/40134261/). *Pediatric transplantation*. [Case Report / Case Series]
Findeisen C (2025). [PMID: 40814602](https://pubmed.ncbi.nlm.nih.gov/40814602/). *Kidney international reports*. [Basic Science / Preclinical]
Chen Q (2025). [PMID: 41399018](https://pubmed.ncbi.nlm.nih.gov/41399018/). *Renal failure*. [Epidemiology / Natural History]
Sudhindar PD (2025). [PMID: 40776899](https://pubmed.ncbi.nlm.nih.gov/40776899/). *Journal of cell science*. [Gene Therapy / Novel Therapeutics]
Nguyen UT (2025). [PMID: 40713318](https://pubmed.ncbi.nlm.nih.gov/40713318/). *Journal of the National Medical Association*. [Case Report / Case Series]
Salehi O (2024). [PMID: 37644229](https://pubmed.ncbi.nlm.nih.gov/37644229/). *Pediatric nephrology (Berlin, Germany)*. [Review / Meta-Analysis]